Occupation and thyroid cancer

Occupational and Environmental Medicine

Volumn 71, Issue 5, 2014, Pages 366-380

  Aschebrook Kilfoy, Briseis ^a   Ward, Mary H ^b   Della Valle, Curt T ^b   Friesen, Melissa C ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PESTICIDE;

AGRICULTURAL WORKER; CANCER INCIDENCE; EMPLOYMENT; ENVIRONMENTAL EXPOSURE; HEALTH CARE; HUMAN; MORTALITY; OCCUPATION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SELF REPORT; TEXTILE INDUSTRY; THYROID CANCER; UNITED STATES; WORK;

AGRICULTURE; HEALTH PERSONNEL; HUMANS; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONS; PESTICIDES; THYROID NEOPLASMS;

EID: 84898544257     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2013-101929     Document Type: Review

References (98)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
2. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009;18:784-91.
3. Kilfoy BA, Devesa SS, Ward MH, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009;18:1092-100.
4. Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009;20:525-31.
5. Davies L, Ouellette M, Hunter M, et al. The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope 2010;120:2446-51.
6. Aschebrook-Kilfoy B, Brown R, Shih YT, et al. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev 2013;22:1252-9.
7. Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J Endocrinol Invest 2012;35(6 Suppl):3-9. Review. PMID: 23014067.
8. Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni J, eds. Cancer epidemiology and prevention. 3rd edn. New York, NY: Oxford University Press, 2006:975-94.
9. Brenner AV, Tronko MD, Hatch M, et al. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect 2011;119:933-9.
10. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259-77.
11. Ron E, Modan B, Preston D, et al. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 1989;120:516-31. (Pubitemid 20022197)
12. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res 1994;137(2 Suppl):S17-67. Review. Erratum in: Radiat Res 1994;139(1):129. (Pubitemid 24060246)
13. Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009;20:181-7.
14. Shore RE, Hildreth N, Dvoretsky P, et al. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993;137:1068-80. (Pubitemid 23191074)
15. Dickman PW, Holm LE, Lundell G, et al. Thyroid cancer risk after thyroid examination with I-131: a population-based cohort study in Sweden. Int J Cancer 2003;106:580-7. (Pubitemid 36966217)
16. 131I in childhood. J Natl Cancer Inst 2005;97:724-32.
17. Davis S, Stepanenko V, Rivkind N, et al. Risk of thyroid cancer in the Bryansk oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat Res 2004;162:241-8. (Pubitemid 39295424)
18. Ron E. Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys 2007;93:502-11. (Pubitemid 350287273)
19. Williams D. Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2008;27(Suppl 2):S9-18.
20. Kim SS, Lee BJ, Lee JC, et al . Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience. Endocrine 2011;39:259-65.
21. Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-14. (Pubitemid 351398557)
22. Boelaert K, Horacek J, Holder RL, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006;91:4295-301. (Pubitemid 44833401)
23. Jonklaas J, Nsouli-Maktabi H, Soldin SJ. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 2008;18:943-52.
24. Polyzos SA, Kita M, Efstathiadou Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 2008;134:953-60.
25. Hiasa Y, Kitahori Y, Kitamura M, et al. Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine. Carcinogenesis 1991;12:873-7.
26. Derwahl M, Broecker M, Kraiem Z. Clinical review 101: thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 1999;84:829-34.
27. Capen CC. Pathophysiology of chemical injury of the thyroid gland. Toxicol Lett 1992;64-5. Spec No:381-8. (Pubitemid 23018777)
28. Williams ED. TSH and thyroid cancer. Horm Metab Res Suppl 1990;23:72-5. Review. (Pubitemid 20269608)
29. Patrick L. Thyroid disruption: mechanism and clinical implications in human health. Altern Med Rev 2009;14:326-46. Review. Erratum in: Altern Med Rev 2010;15(1):58.
30. Miller MD, Crofton KM, Rice DC, et al. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 2009;117:1033-41. Review.
31. Boas M, Feldt-Rasmussen U, Skakkebaek NE, et al. Environmental chemicals and thyroid function. Eur J Endocrinol 2006;154:599-611. Review. (Pubitemid 43810844)
32. Boas M, Main KM, Feldt-Rasmussen U. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes 2009;16:385-91. Review.
33. Crofton KM, Craft ES, Hedge JM, et al. Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism. Environ Health Perspect 2005;113:1549-54. (Pubitemid 41614910)
34. Crofton KM. Thyroid disrupting chemicals: mechanisms and mixtures. Int J Androl 2008;31:209-23.
35. Steenland K, Cedillo L, Tucker J, et al. Thyroid hormones and cytogenetic outcomes in backpack sprayers using ethylenebis(dithiocarbamate) (EBDC) fungicides in Mexico. Environ Health Perspect 1997;105:1126-30. (Pubitemid 28134991)
36. Zoeller TR. Environmental chemicals targeting thyroid. Hormones (Athens) 2010;9:28-40. Review.
37. Blair A, Dosemeci M, Heineman EF. Cancer and other causes of death among male and female farmers from twenty-three states. Am J Ind Med 1993;23:729-42. (Pubitemid 23148374)
38. Blair A, Sandler DP, Tarone R, et al. Mortality among participants in the agricultural health study. Ann Epidemiol 2005;15:279-85. (Pubitemid 40386502)
39. Blair A, Stewart PA, Tolbert PE, et al. Cancer and other causes of death among a cohort of dry cleaners. Br J Ind Med 1990;47:162-8. (Pubitemid 20103739)
40. Omar RZ, Barber JA, Smith PG. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 1999;79:1288-301. (Pubitemid 29087913)
41. Omar RZ, Barber JA, Smith PG. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 1994;70:1232-43. (Pubitemid 24358969)
42. Delzell E, Grufferman S. Cancer and other causes of death among female textile workers, 1976-78. J Natl Cancer Inst 1983;71:735-40. (Pubitemid 14232387)
43. Fillmore CM, Petralia SA, Dosemeci M. Cancer mortality in women with probable exposure to silica: a death certi ficate study in 24 states of the U.S. Am J Ind Med 1999;36:122-8. (Pubitemid 29283635)
44. Robinson CF, Walker JT. Cancer mortality among women employed in fast-growing U.S. occupations. Am J Ind Med 1999;36:186-92. (Pubitemid 29283644)
45. Sorahan T, Parkes HG, Veys CA, et al. Mortality in the British rubber industry 1946-85. Br J Ind Med 1989;46:1-10.
46. Pukkala E, Martinsen JI, Lynge E, et al. Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48:646-790.
47. Hallquist A, Hardell L, Degerman A, et al. Occupational exposures and thyroid cancer: results of a case-control study. Eur J Cancer Prev 1993;2:345-9.
48. Lope V, Pérez-Gómez B, Aragonés N, et al. Occupational exposure to ionizing radiation and electromagnetic fields in relation to the risk of thyroid cancer in Sweden. Scand J Work Environ Health 2006;32:276-84. (Pubitemid 44336254)
49. Lope V, Pérez-Gómez B, Aragonés N, et al. Occupational exposure to chemicals and risk of thyroid cancer in Sweden. Int Arch Occup Environ Health 2009;82:267-74.
50. Fincham SM, Ugnat AM, Hill GB, et al. Is occupation a risk factor for thyroid cancer? Canadian Cancer Registries Epidemiology Research Group. J Occup Environ Med 2000;42:318-22.
51. Ivanov VK, Chekin SY, Kashcheev VV, et al. Risk of thyroid cancer among Chernobyl emergency workers of Russia. Radiat Environ Biophys 2008;47:463-7.
52. Jeong M, Jin YW, Yang KH, et al. Radiation exposure and cancer incidence in a cohort of nuclear power industry workers in the Republic of Korea, 1992-2005. Radiat Environ Biophys 2010;49:47-55.
53. Beane Freeman LE, Rusiecki JA, Hoppin JA, et al. Atrazine and cancer incidence among pesticide applicators in the agricultural health study (1994-2007). Environ Health Perspect 2011;119:1253-9.
54. Lee WJ, Hoppin JA, Blair A, et al. Cancer incidence among pesticide applicators exposed to alachlor in the Agricultural Health Study. Am J Epidemiol 2004;159:373-80. (Pubitemid 38200771)
55. Zielinski JM, Garner MJ, Band PR, et al. Health outcomes of low-dose ionizing radiation exposure among medical workers: a cohort study of the Canadian national dose registry of radiation workers. Int J Occup Med Environ Health 2009;22:149-56.
56. Wong EY, Ray R, Gao DL, et al. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health 2006;79:251-8. (Pubitemid 43085300)
57. Carstensen JM, Wingren G, Hatschek T, et al . Occupational risks of thyroid cancer: data from the Swedish Cancer-Environment Register, 1961-1979. Am J Ind Med 1990;18:535-40. (Pubitemid 20377332)
58. Sigurdson AJ, Doody MM, Rao RS, et al. Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 2003;97:3080-9. (Pubitemid 36676264)
59. Wang JX, Inskip PD, Boice JD Jr, et al. Cancer incidence among medical diagnostic X-ray workers in China, 1950 to 1985. Int J Cancer 1990;45:889-95. (Pubitemid 20179643)
60. Zabel EW, Alexander BH, Mongin SJ, et al. Thyroid cancer and employment as a radiologic technologist. Int J of Cancer 2006;119:1940-5. (Pubitemid 44356855)
61. Lope V, Pollán M, Gustavsson P, et al. Occupation and thyroid cancer risk in Sweden. J Occup Environ Med 2005;47:948-57. (Pubitemid 41306707)
62. Wingren G, Hallquist A, Degerman A, et al. Occupation and female papillary cancer of the thyroid. J Occup Environ Med 1995;37:294-7.
63. Haselkorn T, Bernstein L, Preston-Martin S, et al. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995. Cancer Causes Control 2000;11:163-70. (Pubitemid 30088396)
64. Lie JS, Kjaerheim K, Tynes T. Ionizing radiation exposure and cancer risk among Norwegian nurses. J of Cancer Prevention 2008;17:369-75.
65. Kjaer TK, Hansen J. Cancer incidence among large cohort of female Danish registered nurses. Scand J Work Environ Health 2009;35:446-53.
66. Shaham J, Gurvich R, Kneshet Y. Cancer incidence among laboratory workers in biomedical research and routine laboratories in Israel: part I-the cohort study. Am J Ind Med 2003;44:600-10. (Pubitemid 37448987)
67. Franceschi S, Barbone F, Bidoli E, et al. Cancer risk in farmers: results from a multi-site case-control study in north-eastern Italy. Int J Cancer 1993;53:740-5. (Pubitemid 23100114)
68. Zivaljevic V, Vlajinac H, Jankovic R, et al. Case-control study of female thyroid cancer - menstrual, reproductive and hormonal factors. Eur J Cancer Prev 2003;12:63-6. (Pubitemid 36233024)
69. International Agency for Research on Cancer, Suppl. 4 (1982): IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, chemicals, industrial processes and industries associated with cancer in humans, IARC, Lyon.
70. International Agency for Research on Cancer. Some flame retardants and textile chemicals and exposures in the textile industry. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 48. Lyon: IARC, 1990.
71. Christiani DC, Wegman DH, Eisen EA, et al. Cotton dust and gram-negative bacterial endotoxin correlations in two cotton textile mills. Am J Ind Med 1993;23:333-42.
72. Astrakianakis G, Seixas NS, Camp JE, et al. Modeling, estimation and validation of cotton dust and endotoxin exposures in Chinese textile operations. Ann Occup Hyg 2006;50:573-82. (Pubitemid 44532892)
73. Wingren G, Hatschek T, Axelson O. Determinants of papillary cancer of the thyroid. Am J Epidemiol 1993;138:482-91. (Pubitemid 23315083)
74. Enewold L, Zhou J, Devesa SS, et al. Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004. Cancer Epidemiol Biomarkers Prev 2011;20:2369-76.
75. Reynolds P, Elkin EP, Layefsky ME, et al. Cancer in California school employees, 1988-1992. Am J Ind Med 1999;36:271-8. (Pubitemid 29328190)
76. Sathiakumar N, Delzell E, Rodu B, et al. Cancer incidence among employees at a petrochemical research facility. J Occup Environ Med 2001;43:166-74. (Pubitemid 32172454)
77. Bates MN. Registry-based case-control study of cancer in California firefighters. Am J Ind Med 2007;50:339-44. (Pubitemid 46786851)
78. Wingren GB, Axelson O. Occupational and environmental determinants for benign thyroid disease and follicular thyroid cancer. Int J Occup Environ Health 1997;3:89-94. (Pubitemid 127816929)
79. Preston-Martin S, Jin F, Duda MJ, et al. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 1993;4:431-40. (Pubitemid 23290758)
80. Goldner WS, Sandler DP, Yu F, et al. Pesticide use and thyroid disease among women in the Agricultural Health Study. Am J Epidemiol 2010;171:455-64.
81. Goldner WS, Sandler DP, Yu F, et al. Hypothyroidism and pesticide use among male private pesticide applicators in the agricultural health study. J Occup Environ Med. 2013;55:1171-8.
82. Ward MH, Kilfoy BA, Weyer PJ, et al. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 2010;21:389-95.
83. Meeker JD, Ferguson KK. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in U.S. adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007-2008. Environ Health Perspect 2011;119:1396-402.
84. Baan R, Grosse Y, Straif K, et al. WHO international agency for research on cancer monograph working group. A review of human carcinogens - Part F: chemical agents and related occupations. Lancet Oncol 2009;10:1143-4.
85. El Ghissassi F, Baan R, Straif K, et al. WHO international agency for research on cancer monograph working group. A review of human carcinogens - part D: radiation. Lancet Oncol 2009;10:751-2.
86. Straif K, Benbrahim-Tallaa L, Baan R, et al. WHO international agency for research on cancer monograph working group. A review of human carcinogens - part C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009;10:453-4.
87. Pearce EN, Braverman LE. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:801-13. Review.
88. Bastian TW, Prohaska JR, Georgieff MK, et al. Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology 2010;151:4055-65.
89. Mahmood T, Qureshi IZ, Iqbal MJ. Histopathological and biochemical changes in rat thyroid following acute exposure to hexavalent chromium. Histol Histopathol 2010;25:1355-70.
90. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS ONE 2012;7:e29177.
91. Kilfoy BA, Zhang Y, Park Y, et al. Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study. Int J Cancer 2011;129:160-72.
92. Rice C, Birnbaum LS, Cogliano J, et al. Exposure assessment for endocrine disruptors: some considerations in the design of studies. Environ Health Perspect 2003;111:1683-90. (Pubitemid 37265983)
93. Duntas LH, Doumas C. The 'rings of fire' and thyroid cancer. Hormones (Athens) 2009;8:249-53.
94. Mannetje A, Kromhout H. The use of occupation and industry classifications in general population studies. Int J Epidemiol 2003;32:419-28. (Pubitemid 36764101)
95. Stewart P. Challenges to retrospective exposure assessment. Scand J Work Environ Health 1999;25:505-10. Review. (Pubitemid 30015686)
96. Teschke K, Olshan AF, Daniels JL, et al. Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med 2002;59:575-93; discussion 594.
97. Kennedy SM, Koehoorn M. Exposure assessment in epidemiology: does gender matter? Am J Ind Med 2003;44:576-83. (Pubitemid 37448984)
98. Zahm SH, Blair A. Occupational cancer among women: where have we been and where are we going? Am J Ind Med 2003;44:565-75. (Pubitemid 37448983)